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Abstract A key step in heart development is the coor-
dinated development of the atrioventricular canal (AVC),
the constriction between the atria and ventricles that elec-
trically and physically separates the chambers, and the
development of the atrioventricular valves that ensure
unidirectional blood ﬂow. Using knock-out and inducible
overexpression mouse models, we provide evidence that
the developmentally important T-box factors Tbx2 and
Tbx3, in a functionally redundant manner, maintain the
AVC myocardium phenotype during the process of
chamber differentiation. Expression proﬁling and ChIP-
sequencing analysis of Tbx3 revealed that it directly
interacts with and represses chamber myocardial genes,
and induces the atrioventricular pacemaker-like phenotype
by activating relevant genes. Moreover, mutant mice
lacking 3 or 4 functional alleles of Tbx2 and Tbx3 failed to
form atrioventricular cushions, precursors of the valves and
septa. Tbx2 and Tbx3 trigger development of the cushions
through a regulatory feed-forward loop with Bmp2, thus
providing a mechanism for the co-localization and coor-
dination of these important processes in heart development.
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Introduction
Atria and ventricles arise in a highly localized fashion from
an initially linear tube in the embryonic heart. These
embryonic chambers feature an increased cell proliferation
and a working type of myocardial gene program. They are
initially separated by the atrioventricular canal (AVC) that
by virtue of its lower cell division rate provides a primitive
morphological constriction. Because the myocardial lining
of the AVC remains of a primitive type with low con-
ductivity [1], it will delay the propagation of the electrical
impulse between atria and ventricles. Most of the myo-
cardial investment of the AVC will have disappeared by
the end of gestation, but some nodal type of cells remain
and form the AV junction and AV node, and continue to
relay the impulse to the ventricles. Furthermore, the
AV myocardium induces the overlying endocardium to
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123undergo an epithelial–mesenchymal transition (EMT) and
to invade the cardiac jelly, an extracellular matrix (ECM)
that is deposited by the primary myocardium. These mes-
enchymal cushions are subsequently remodeled into thin
valve leaﬂets, AV insulation, and components of the septa
that ensure structural and functional compartmentalization
of the heart [2–4].
Given the common developmental origin of AV nodal
cells, insulation and valves, it may not be surprising that
patients with congenital AVC defects often suffer from
additional conduction problems, and that patients with
Ebstein’s anomaly, where the tricuspid valve is incorrectly
positioned and hypomorphic, frequently display ventricular
pre-excitation [5]. These observations indicate a common
regulatory pathway for the formation of the AVC/con-
duction system and the mesenchymal components of
valves and septa.
BMP signaling plays a critical role in both AVC spec-
iﬁcation and the formation of cushion tissue [4].
Myocardial bone morphogenetic protein 2 (Bmp2) acti-
vates myocardial expression of the transcriptional repressor
T-box 2 (Tbx2), and is thought to directly induce cushion
formation in the adjacent endocardium [2, 3, 6–9]. Addi-
tionally, Tbx2 inhibits the chamber myocardial gene
program in the AVC [10–12]. Tbx3 is genetically and
functionally related to Tbx2, and suppresses chamber dif-
ferentiation of the sinus node, the AV bundle and bundle
branches [13, 14]. Tbx2 and Tbx3 expression overlaps in
the AVC, suggesting that functional redundancy has pre-
vented a full appreciation of their role in the development
of this tissue to date [12]. Here, we present data in the
mouse that implicate a feed-forward loop between Tbx2/
Tbx3 and Bmp2 in this tissue.
Materials and methods
Mice and genotyping
Mouse work was performed in accordance with national
and international guidelines
Mice carrying a null allele of Tbx2 (Tbx2
tm1.1(cre)Vmc,
synonyms: Tbx2
-, Tbx2
Cre)[ 10] and/or Tbx3
(Tbx3
tm1.1(cre)Vmc, synonyms: Tbx3
-, Tbx3
Cre)[ 13] and
mice for Cre-mediated misexpression of Tbx2 or Tbx3,
NppaCre [15], Myh6Cre [16], Myh6-MerCreMer [17] and
CAG-CAT-TBX3 (CT3)[ 13], and Nkx2-5
Cre/? and
Bmp2
ﬂoxneo/- [3] were previously described. For condi-
tional misexpression of Tbx2,aTbx2 expression cassette
was introduced in the Hprt locus (HpCT2) (see online data
supplement). All strains were maintained on outbred
(NMRI or FVB/N) background.
Generation of the Hprt
TBX2 allele
A ‘knock-in’ strategy into the X-chromosomal hypoxan-
thine guanine phosphoribosyl transferase (Hprt) gene
locus was designed to replace mayor parts of the Hprt exon
1 (including the ATG) by a cassette suited for cre-mediated
(mis-) expression described previously [18]. Homologous
recombination results in a functional Hprt null allele,
allowing direct selection of successfully targeted ES cells
by 6-Thioguanine. The targeting vectors contained a 2.2-
kbp 50-homology region, followed by the ubiquitously
expressed CMV early enhancer/chicken b-actin (CAG)
promoter, the conditional expression cassette [18], and a
5.1-kbp 30-homology region. The open reading frame
(ORF) of human TBX2 (cDNA NM_005994.3) [19] was
ﬁrst subcloned in the vector pSL1180 (GE-healthcare), 50 of
an IRES-EGFP sequence, and then shuttled as 50-NheI-
ORF-IRES-EGFP-MluI-30 fragment into the MluI and NheI
sites of the targeting vector. This results in a reverse ori-
entation of the ORF, relative to the CAG promoter,
avoiding ‘leaky’ expression. After cre-mediated ‘ﬂipping’-
and excision events between pairs of loxP and loxM
sequences, the ORF locates in sense direction, directly
downstream of the CAG promoter. The targeting vector
was veriﬁed by sequencing before linearization and elec-
troporation in Hprt-positive SV129 ES cells (maintained
beforehand in HAT medium). A two-step selection prot-
ocol was employed, starting 24 h after electroporation
with the addition of 100 lg/ml G418, followed by the
addition of 1.67 lg/ml 6-Thioguanine (Sigma) after an
additional 5 days. Surviving colonies were expanded and
genotyped by PCR (conditions are available upon request).
To test the functionality of the expression cassette in can-
didate ES clones, the GFP epiﬂuorescence was analyzed
6 days after electroporation with a cre-expression plasmid
(pCAG::turbo-cre, kind gift from Achim Gossler). Veriﬁed
ES clones were microinjected into CD1 mouse blastocysts.
Chimeric males were obtained and mated to NMRI females
to produce heterozygous F1 females.
Generation and isolation of transgenic embryos/mice
For the generation of Tbx2 or Tbx3 mutant embryos, mice
heterozygous for Tbx2 or Tbx3 null alleles were inter-
crossed. For the generation of double-mutant embryos,
double-heterozygous mice were intercrossed. Double-
transgenic mice conditionally expressing TBX3 in the atria
and the whole heart were generated by crossing CT3 mice
with NppaCre or Myh6Cre mice, respectively. Double-
transgenic mice conditionally expressing Tbx2 in the whole
heart were generated by crossing HpCT2 mice with
Myh6Cre or Mox2
Cre mice. For timed pregnancies, vaginal
plugs were checked in the morning after mating, noon was
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123taken as embryonic day (E) 0.5. Embryos were harvested in
PBS, ﬁxed in 4% paraformaldehyde overnight and stored in
100% methanol at -20C before further use. Wild-type
littermates were used as controls. Genomic DNA prepared
from yolk sacs or tail biopsies was used for genotyping by
PCR (see supplementary table 6).
Embryonic heart explant assay
Atria from Myh6-Cre;HpCT2 and control (Myh6-Cre)
E10.5 embryos were dissected, individually placed on
Transwell ﬁlters and cultured for 4 days in presence or
absence of 30 lM Dorsomorphin in explant medium
(Optimem supplemented with Penicillin/Streptomycin,
Glutamax, FCS (2%), Insuline/Transferrin/Selenium).
Total RNA was extracted with RNAPure reagent (Peqlab)
and DNaseI (Roche) treated for 30 min at 37C. RNA was
reverse transcribed with RevertAid H-minus M-MuLV
reverse transcriptase (Fermentas). For semi-quantitative
PCR, the number of cycles was adjusted to the mid-loga-
rithmic phase. Quantiﬁcation was performed with Quantity
One software (Bio-Rad). Normalization was against Gap-
dh. Assays were performed at least twice in duplicates.
P values were calculated using the unpaired two-tailed
Student’s t test. See supplementary table 6 for primer
sequences and PCR conditions.
Sample preparation, RNA isolation, and gene
expression analysis
Left atria of six NppaCre;CT3 mice and six control (Npp-
aCre) mice (male, 6 weeks) were dissected and snap frozen
inliquidnitrogen.TotalRNAwasisolatedandpuriﬁedusing
single prep nucleospin columns according to the manufac-
turer’s instructions (Macherey–Nagel). RNA quality was
checked usinga bioanalyzer (Agilent Technologies). A total
of 250 ng of total RNA was used for biotin-16-UTP cRNA
labeling and ampliﬁcation using the Illumina RNA ampliﬁ-
cation kit (Ambion Inc., Austin, TX). Labeled RNA was
hybridized to Illumina MouseRef-6 BeadChip following the
manufacturer’s instructions (Illumina Inc., San Diego, CA).
ThearrayswerescannedusinganIlluminaBeadarrayreader
confocal scanner. BeadStudio software was used to assess
the individual array quality. Unprocessed intensity values
were averaged perbeadtype,exported fromBeadStudioand
subsequently normalized using VSN in R [20]. Genes were
tested for signiﬁcant differential expression using the
empirical Bayes moderated t-statistics test in the R-Limma
package [21] at a 5% Benjamini–Hochberg false discovery
rate[22].Wefoundthattheexpressionof737transcriptswas
signiﬁcantlyreducedinatriaofNppaCre;CT3mice,whereas
809 transcripts were signiﬁcantly induced (threshold:
p value\0.05).
Geneset analysis and GO term selection
The Global test [23] was used to test for signiﬁcant associ-
ationofspeciﬁcGOtermswiththedifferencesinphenotypes
between the NppaCre;CT3 and NppaCre mice. A series of
selection criteria was applied to reduce the list of signiﬁcant
GO terms, i.e., Benjamini–Yekutieli FDR at 15% and the
number of genes in the geneset between 10 and 75. The
individual inﬂuence of each gene on the test statistics was
calculated and used as an additional level of GO term
selection,i.e.,atleastﬁvegenespergenesetwithaninﬂuence
above 5, representing at least 5% of the geneset.
Quantitative real-time PCR analysis
Quantitative real-time PCR analysis was performed as descri-
bed previously [13]. In short, total RNA was isolated from left
atrial appendices of 4-week-old adult mice using the RNeasy
mini kit according to the manufacturer’s protocol (Qiagen).
cDNA was reverse transcribed from 300 ng total RNA using
the superscript II system (Invitrogen) and expression of dif-
ferentgeneswasassayedwithquantitativereal-timePCRusing
the Roche 480 Lightcycler. Relative start concentration (N(0))
was calculated as described previously [24]. Values were nor-
malized to Gapdh expression levels. Primers sequences are
provided in the online supplemental table 6.
In situ hybridization and immunohistochemistry
Non-radioactive in situ hybridization was performed as
described previously [25]. Probes for Bmp10, Sox9, Fbln2,
and Id3 were kindly provided by Herman Neuhaus, Benoit
de Crombrugghe and Yvette Chin. IMAGE cDNA con-
structs were kindly provided by Fred van Ruissen. The
following IMAGE cDNA constructs were digested with
SalI and labeled with T7 RNA polymerase to generate
DIG-labeled probes used for in situ hybridization: Tagln
(BC003795), Fbln2 (BC005443), Lum (BC005550), Nkd2
(BC019952), Meox1 (BC011082), Ednra (BC008277), and
Aldh1b1 (BC020001). Fgf12, Cacna2d2, and Hnt probe
construct were generated by PCR ampliﬁcation using gene-
speciﬁc primers and were subsequently cloned into
pBluescript SK vector for DIG labeling. For immunohis-
tochemistry, the same ﬁxation protocol as for the in situ
hybridization analysis was used. Primary antibodies used
were as follows: anti-cleaved caspase 3 (Cell Signaling,
#9661 polyclonal) and anti-phosphohistone H3 (Cell Sig-
naling, #9701 polyclonal).
ChIP data analysis
Conditional TBX3 over-expressing and cardiac speciﬁc
tamoxifen inducible Cre (Mer-Cre-Mer) mice have been
Tbx2 and Tbx3 in conduction system and cushion development 1379
123described before [13, 17]. Male mouse hearts were isolated
4 days after intra-peritoneal injections of tamoxifen, and
TBX3 over-expression was conﬁrmed by qRT-PCR, in situ
hybridization and immunohistochemistry (not shown).
ChIP was performed on mouse hearts using anti-TBX3
(A-20, Santa-Cruz). In this case, Mer-Cre-Mer mice,
lacking the TBX3 expression construct, injected with
tamoxifen served as ChIP control. Isolated DNA fragments
were analyzed using high-throughput sequencing (data and
analysis will be published elsewhere). Data signiﬁcance of
TBX3 binding peaks were analyzed using Fisher’s exact
test with comparison to ChIP control data.
Transcription factor binding site prediction
To identify potential T-box binding sites, high-quality
position weight matrices from Jaspar database were used
(http://jaspar.genereg.net/; MA0009.1 for T-box binding
sites). The relative score threshold was set to 70%.
Results
Tbx2 and Tbx3 are redundantly required for AVC
patterning
Previous analyses indicated that Tbx2 is necessary and
sufﬁcient to suppress chamber gene expression in the AVC
[10, 11, 26]. However, in our Tbx2 loss-of-function mouse
AVC formation at E9.5 was grossly normal, and natriuretic
peptide type A (Nppa/ANF) and other chamber markers
were not ectopically expressed in the AVC [10]. Tbx2 is
co-expressed in the AVC myocardium with the closely
related family member Tbx3 arguing for functional
redundancy of the two genes in this region. We wished to
test this hypothesis by generating mice double mutant for
Tbx2 and Tbx3. This effort was largely hampered by the
fact that mice double heterozygous for Tbx2 and Tbx3 null
alleles with a high penetrance exhibited postnatal lethality
due to craniofacial defects [27]. Nonetheless, we managed
to obtain some double-heterozygous animals for further
interbreeding. Viable Tbx2
-/-;Tbx3
-/- embryos from few
litters at E9.5 appeared slightly retarded in their develop-
ment, most likely due to arising hemodynamic failure.
Morphologically, the constriction between the left ventricle
and the atrium was largely absent (Fig. 1). Markers of
chamber myocardium [Nppa, gap junction protein, alpha 5
(Gja5/Cx40)] [26] were expanded into this region whereas
homozygous mutants for either Tbx2 or Tbx3 and double
heterozygous mutants showed proper chamber gene
repression in the AVC (Fig. 1; data not shown). Cre from
the mutant alleles reﬂecting endogenous expression from
either Tbx2 or Tbx3 or both in the absence of Tbx2 or Tbx3
protein, was present, although reduced in Tbx2
-/-;Tbx3
-/-
embryos (Fig. 1, arrows), indicating that early AVC spec-
iﬁcation had occurred.
A Bmp2-Tbx2/3 feed-forward loop is required for EMT
and formation of cushion mesenchyme in the AVC
Histological analysis of embryos compound mutant for null
alleles of Tbx2 and Tbx3 revealed that loss of more than
two functional alleles resulted in reduction of cardiac jelly
and absence of AV cushion formation (Fig. 2). Bmp2
expression in the AVC myocardium is both required and
sufﬁcient to induce cushion formation and EMT of the
adjacent endocardium [2, 3, 6]. Both Tbx2 and Tbx3 were
downregulated in Nkx2-5
Cre;Bmp2
ﬂoxneo/ﬂoxneo embryos, in
which Bmp2 was inactivated in the heart (Fig. 3a), sug-
gesting that the two genes are downstream mediators of
Bmp signaling in this region. Expression of Bmp2 was
normal in single mutants but reduced in compound mutants
indicating the presence of a feed-forward loop between
Bmp2 and Tbx2/Tbx3 (Fig. 3b). Consistently, expression
of transforming growth factor, beta 2 (Tgfb2), a Bmp2
target in this tissue that is required for cushion formation
and of hyaluronan synthase 2 (Has2), required for cardiac
jelly formation and AV cushion development [2, 28] was
downregulated in the AVC endocardium and myocardium
of both Nkx2–5
Cre;Bmp2
ﬂoxneo/ﬂoxneo embryos and com-
pound Tbx2/3 mutants (Online Fig. 1). Hence, Tbx2 and
Tbx3 are required in a redundant fashion to maintain the
primary myocardium of the AVC, to maintain Bmp2
expression, and to induce the formation of cushion tissue
from the endocardium in this region.
Myocardial Tbx2 and Tbx3 induce mesenchymal
cushion formation
To further elucidate the role of Tbx2 and Tbx3 in AVC and
cushion development we used gain-of-function approaches
to ectopically express Tbx2 and Tbx3 during early heart
development. We crossed mice that harbored a Cre-acti-
vatable Tbx2 expression cassette in the transcriptionally
competent Hprt locus (HpCT2) with Myh6Cre mice
(Fig. 4a). Double-heterozygous Myh6Cre;HpCT2 embryos
survived until E13.5–E14.5. Widespread activation of Tbx2
in the myocardium of the embryonic heart occurred rela-
tively late at low levels, explaining the formation of
chambers and the lack of early lethality observed previ-
ously using a constitutive over-expression approach [26].
Histological and in situ hybridization analyses revealed
that ectopically expressed Tbx2 suppressed the expression
of chamber markers Gja5 and Nppa at E11.5 as expected
(Fig. 4b and not shown). Formation of ectopic sub-
endocardial mesenchyme was observed in the atria, and to
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ceptible to signals initiating cushion formation. Bmp2 was
strongly induced in the atrial myocardium, whereas Notch
gene homolog 1 (Notch1), a Bmp2 target which regulates
EMT in the endocardium [2, 4], and Has2, were induced in
the endocardium overlying the transgenic Tbx2
? myocar-
dium (Fig. 4b).
We next wished to test whether induction of endocardial
cushion formation by Tbx2 depends on Bmp2 signaling.
For this purpose, we cultured explanted E10.5 Myh6-
Cre;HpCT2 atria for 4 days in the absence or presence of
30 lM Dorsomorphin, an inhibitor of Bmp type 1 recep-
tors. qRT-PCR assays revealed that all markers for EMT
and cushion formation tested were down-regulated in the
presence of Dorsomorphin (Online Fig. 2), providing fur-
ther evidence that Tbx2-mediated EMT and cushion
formation depends on Bmp-signaling.
To investigate whether Tbx3 is also sufﬁcient to induce
cushion formation, we ectopically activated Tbx3 expres-
sion in the developing heart using the Myh6Cre line and the
Cre-activatable transgenic Tbx3 cassette reported on earlier
CAG-CAT-TBX3 (CT3)[ 13] (Fig. 4c). Loss of Gja5 and
Bmp10 expression conﬁrmed functional TBX3 overex-
pression in double heterozygous (Myh6Cre;CT3) mice.
Myh6Cre;CT3 embryos featured hypoplastic chamber
walls, and the fraction of phospho-Histone 3-positive pro-
liferating cells in the ventricular walls was reduced
(Fig. 4d). In contrast, ectopic TBX3 expression did not
result in induced apoptosis as deﬁned by TUNEL assays
(not shown). These results suggest that Tbx3 contributes to
the low proliferation of the AVC myocardium. Bmp2 was
ectopically activated in the myocardium of Myh6Cre;CT3
embryos, whereas snail homolog 1 (Snai1), a Notch1/
Tgfb2 target required for AVC EMT[4] and Has2 were
ectopically activated in the overlying endocardium
(Fig. 4e). Moreover, a large subendocardial space formed
that, closer to the AV cushions, was ﬁlled with mesen-
chymal cells expressing the cushion marker MAD homolog
6 (Smad6) (* in Fig. 4e; Online Fig. 3).
We next assessed the consequences of prolonged cardiac
expression of Tbx3 using NppaCre to activate Tbx3 from
E10 onwards in the atrial myocardium in the CT3 mice
(Fig. 5a) [13]. E17.5 fetuses formed a thick sub-endocar-
dial layer of cells in the atria. This tissue expressed
Fig. 1 Combined loss of Tbx2
and Tbx3 abrogates myocardial
patterning of the atrioventricular
canal. Comparative analysis of
wild-type, Tbx2
-/-,
Tbx2
-/-;Tbx3
-/- and Tbx3
-/-
embryos for cardiac
morphology and molecular
marker expression at E9.5. Left
lateral views of whole E9.5
embryos and enlarged hearts
(boxed regions in upper row
shown in second row) reveal
growth retardation and dilated
avc phenotype in Tbx2/Tbx3
double mutant embryos. In situ
hybridization analysis of marker
gene expression in sagittal
sections through the avc with
probes as indicated. avc
atrioventricular canal, la left
atrium, lv left ventricle
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smooth muscle, aorta (Acta2/a-SMA), ﬁbulin 2 (Fbln2),
versican (Cspg2/Vcan) and lumican (Lum) (Fig. 5b–d,
Supplemental Table 1) that are associated with AV cush-
ions. Furthermore, Tgfb2, Bmp6, inhibitor of DNA binding
3 (Id3) and SMAD family member 6 (Smad6) were induced
in the endocardial layers (Fig. 5c, Supplemental Fig. 4,
Supplemental Table 1). Taken together, both Tbx2 and
Tbx3 in myocardium are sufﬁcient to induce cushion for-
mation and EMT in the adjacent endocardium.
Identiﬁcation of endocardial mesenchyme gene
programs downstream of myocardial Tbx3
We used the NppaCre;CT3 transgenic model to gain deeper
insight into the mechanism of gene regulation by Tbx3.
Genome-wide microarray analyses (Illumina MouseRef-6
oligonucleotide BeadChips, 47,769 different oligonucleo-
tides) were performed, comparing the atrial gene expression
proﬁle of six male double-transgenic NppaCre;CT3 mice
and six male NppaCre control mice. Expression of 737
transcripts was signiﬁcantly reduced in atria of Npp-
aCre;CT3 mice, whereas 809 transcripts were signiﬁcantly
induced(threshold:pvalue\0.05).ComponentsoftheTgfb-
, Bmp-, Fgf- and Wnt-signaling pathways that have been
functionally implicated in AV cushion and valve formation
[2] were highly up-regulated in atria of NppaCre;CT3
comparedtoNppaCrecontrolmice(SupplementalTable 1).
Furthermore,GOtermsassociatedwithEMT,suchasTGF-b
receptor signaling pathway, collagen and ECM were over
represented in genes with overall higher expression in atria
of NppaCre;CT3 (Supplemental Table 2). In addition, qRT-
PCRand insitu hybridization analysis conﬁrmed expression
of genes in the subendocardial mesenchyme of Npp-
aCre;CT3 mice (Twist1, Msx1, Meox1, Sox9, Id3, and
Smad6) (Fig. 5d, Supplemental Fig. 4, Supplemental
Table 1), whose expression and functional relevance in
EMT and cushion formation in the AVC have been reported
[2–4]. Furthermore, expression of Fgfr2, and of Wnt antag-
onists Frzb, Sfrp2 and Nkd2 was detected in the cushion
mesenchyme and up-regulated in atria of NppaCre;CT3
mice, compatible with the established requirement for Fgf-
and Wnt-signaling in cushion and valve formation (Fig. 5d,
Supplemental Fig. 5, Supplemental Table 1) [2]. Pkd2 is
normally expressed in the developing valves and was
induced in atrial mesenchyme of NppaCre;CT3 mice
(Fig. 5d). In human and mouse, mutations of Pkd2 result in
valve abnormalities [29]. An additional 47 induced genes
were identiﬁed in the microarray data whose speciﬁc
expression in the fetal AV valvular mesenchyme was
reported by Genepaint (http://www.genepaint.org/) (Sup-
plemental Table 3). Furthermore, we provide a list of genes
associated with cushion formation and EMT, as generated
withtheliterature-basegeneannotationtoolAnni2.0[30]in
Supplemental Table 4. This list contains established (e.g.
Tgfb2, Gata4) as well as potential new players in cardiac
cushion formation/EMT. Gli pathogenesis related protein-2
(Glipr-2), for instance, has been shown to be up-regulated
during tissue ﬁbrosis, a common pathway in the progression
of many chronic disease states, and have the capacity to
induce EMT in renal epithelial cells [31]. Further, both Tnc
(Tenascin-C), Timp1 (Tissue inhibitor of matrix metallo-
proteinase 1) and Hgf have been linked to EMT via their
involvementintheremodelingprocessesoftheextracellular
matrix and effects on cell motility during cellular migration
[31–33].
Tbx3 imposes a nodal gene program on atrial
myocardium
Weobserveddown-regulationofknownandnovelchamber-
speciﬁc genes in Tbx3-expressing atria of NppaCre;CT3
mice (Supplemental Table 1). qRT-PCR and in situ
Fig. 2 Combined loss of more than two alleles of Tbx2 and Tbx3
abrogates cushion formation in the AVC. Histological analysis of
sagittal sections through the left atrium (la), atrioventricular canal
(avc), and left ventricle (lv) by hematoxylin and eosin (H and
E) staining shows normal cushion formation upon loss of one or two
functional alleles of Tbx2 and Tbx3 (a, c, e), whereas loss of more
than two functional alleles of the two genes results in partial loss of
cardiac jelly and complete loss of AV cushion tissue (b, d, f). avc
atrioventricular canal, a atrium, lv left ventricle
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expression and TBX3-mediated atrial repression of Ckm
[34],Nppb[35],Aldh1b1andEdnra[36],andofBmp10[37]
(Fig. 5d, Supplemental Fig. 4, 5). Furthermore, atria of
NppaCre;CT3 mice had reduced expression of genes
involved inmuscle contractility,suchassarcomerecomplex
genes and genes associated with mitochondria and their
energy metabolism (Online Table 1). Consistently, com-
pared to working myocytes, nodal (conduction system)
myocytes feature a much poorer myoﬁbril differentiation
and sparser mitochondria [1].
Microarray analysis and subsequent validation by qRT-
PCR and/or in situ hybridization revealed induction of
genes in NppaCre;CT3 atria including Bmp2, Cx45/Gja7,
Itpr1, Slco3A1, Id2, Cacna2d2, and Hnt (Fig. 5b–d, Sup-
plemental Fig. 5, Supplemental Table 1), normally
enriched in conduction system components, including the
AV node. These genes are associated with (Slco3A1)o r
involved in the formation (Id2, Bmp2) or function (Cx45,
Itpr1) of the conduction system [1, 3, 38–40]. Regulatory
sequences of the Slco3A1 gene are thought to drive reporter
gene expression of the cardiac conduction system reporter
Fig. 3 A Bmp2-Tbx2/3
regulatory feed-forward loop for
expression in the
atrioventricular canal.
a Inactivation of Bmp2 in
cardioblasts or embryonic
cardiomyocytes by Nkx2–5
Cre
results in loss of Tbx2 and Tbx3
expression in the
atrioventricular canal (asterisk).
b In both compound Tbx2/Tbx3
mutants and Bmp2 conditional
mutants, the atrioventricular
constriction is largely absent.
Bmp2 expression is lost from
Tbx2/Tbx3 compound mutants,
whereas reduced levels of Bmp2
transcripts (lacking exon 3; [3])
can still be found in the Bmp2
conditional mutants (asterisk).
avc atrioventricular canal,
a atrium, lv left ventricle
Tbx2 and Tbx3 in conduction system and cushion development 1383
123(CCS)-lacZ mouse strain [39]. Calcium channel subunit
Cacna2d2 and Hnt, which are enriched in the sinus and AV
node of adult mice [41] and in the developing cardiac
conduction system, including the AVC (Online Fig. 5),
were strongly induced in the atria of NppaCre;CT3 mice
(Fig. 5, Supplemental Table 1).
We complemented the microarray analysis by per-
forming ChIP-seq assays on hearts of mice in which Tbx3
was activated in the myocardium using tamoxifen-induced
Cre recombination (due to technical limitations we were
not able to obtain ChIP-seq data for endogenous Tbx3 from
embryonic hearts). We observed several thousand peaks in
the genome of Myh6-MerCreMer;CT3 mice, whereas
tamoxifen-treated Myh6-MerCreMer mice did not yield
speciﬁcally localized peaks. Interaction with T-box binding
elements (TBEs) previously identiﬁed by mutational and in
vitro binding analyses (Nppa, Myh6, Gjd3/Cx30.2, Id2)
[38, 42–45], conﬁrms the quality of the ChIP-seq data, and
implies that Tbx3 directly regulates these genes in vivo
(Fig. 6a, b, Supplemental Fig. 6). Moreover, binding of
Tbx5 and Gata4, derived from recently published resource
of ChIP-seq data from the heart derived cell line HL-1
(GEO: GSE21529) [46] coincided with Tbx3 peaks found
in these loci (Fig. 6a, b). Analysis of the overlap between
the microarray and the Tbx3 ChIP-seq data sets (online
supplemental table 5) revealed a signiﬁcant enrichment of
Tbx3 binding peaks associated with both up- and down-
regulated genes. Furthermore, down-regulated genes were
associated with signiﬁcantly more Tbx3 binding peaks than
up-regulated genes, in keeping with the notion that Tbx3
Fig. 4 Cardiac misexpression
of Tbx2 or Tbx3 induces cardiac
jelly and cushion formation in
chamber myocardium. a Use of
Myh6Cre driver to ectopically
activate Tbx2 in the
myocardium. b Robust
activation of Tbx2 (Gfp)i n
Myh6Cre;HpCT2 leads to loss
of Nppa and induction of Bmp2
in the myocardium, and Fbln2,
Has2 and Notch1 in
endocardium/mesenchyme (red
arrows). c Transgenic
constructs used to activate Tbx3
in the myocardium of the
embryonic heart.
d Immunohistochemical
analysis of proliferation (PHH3)
in E11.5 hearts of
Myh6Cre;CT3 mice compared
to control (CT3) mice. Black
arrows depict Phospho-H3
positive cells in the ventricular
myocardium of control mice
and Myh6Cre;CT3 mice. Black
bar, 100 lm. e In situ
hybridization of serial sections
in E11.5 hearts of
Myh6Cre;CT3 mice compared
to control mice. Snai1 and Has2
are induced in the endocardium
and subendocardial
mesenchyme formed in the atria
of Myh6Cre;CT3 embryos
(asterisk). avc atrioventricular
canal, l/ra left/right atrium, l/rv
left/right ventricle
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123acts as a strong transcriptional repressor in vitro and in cell
culture. Overlap of the Tbx3-enriched datasets with the
Tbx5 ChIP-seq data obtained in HL1 cardiac-like cells
revealed an average association of 90% of these enriched
genes with Tbx5 [46]. The observed interaction with the
region of Nppb, Hcn4, Acta2, Cacna2d2, Bmp2 and Bmp4
suggests that T-box factors also directly regulate these
genes (Fig. 6b, c; Online Fig. 7). Two genes that are not
inﬂuenced by Tbx3 in the myocardium but indirectly in the
endocardium, Has2 and Sox9, were indeed devoid of any
Tbx3 peaks (Online Fig. 7).
Closer inspection of the Bmp2 locus revealed one par-
ticular genomic site with which Tbx3 interacts (Fig. 6c). In
the developing heart, enhancer associated co-factor p300
was also found to interact with this region (Fig. 6c) [47].
When isolated and tested in transfection assays, this frag-
ment stimulated reporter gene expression in cardiac-like
H10 cells and responded to T-box factors (Fig. 6d). These
Fig. 5 Myocardial Tbx3
expression induces endocardial
mesenchyme formation and
nodal gene expression.
a Transgenic constructs used to
activate TBX3 in the developing
atria. b, c Sections of E17.5
atria of CT3 and NppaCre;CT3
mice were probed for
expression of indicated genes.
Black arrowhead indicates the
sinus node (san), white
arrowhead the myocardium.
Red arrowheads depict the thick
endocardial mesenchymal layer
that forms in NppaCre;CT3
atria. Black bar, 100 lm.
d qRT-PCR analysis of left atria
of NppaCre;CT3 double-
transgenic mice compared to
CT3 control mice. Expression
levels in CT3 atria were set to 1.
*p\0.05. ra right atrium, san
sinus node
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123data suggest that Bmp2 may be directly regulated by T-box
factors including Tbx3 in the myocardium.
Discussion
Tbx2 and Tbx3 regulate chamber versus AVC
development
Our study reveals that the T-box transcription factor Tbx2
together with Tbx3 locally repress chamber differentiation,
stimulate development of the AVC myocardium and AV
nodal phenotype, and induce AV cushion development,
providing a mechanism for the co-localization and coor-
dination of these important processes in heart development.
Tbx2 and Tbx3 are an evolutionary closely related pair
of T-box proteins that share identical biochemical proper-
ties and are co-expressed in the AVC (reviewed in [48]).
Hence, Tbx2 and Tbx3 may be functionally redundant in
their requirement for AVC establishment. Our data con-
ﬁrmed this hypothesis. Individual loss of function of either
Tbx2 or Tbx3 did not have a major impact on AVC
Fig. 6 Tbx3 ChIP-seq reveals
interaction with known and
novel binding sites in vivo.
a Tbx3 binds to the region
upstream of Cx30.2 (Gjd3), a
region shown to function as a
T-box responsive enhancer [44].
The relative position and
sequence of the published T-box
binding elements and
conservation are shown at the
bottom of the panel (red).
Recently published Gata4 and
Tbx5 ChIP-seq data from HL-1
cells [46] also shows speciﬁc
binding within this region.
b The TBE of Nppa [42, 43], is
occupied by Tbx3 in atria and
by Tbx5 and Gata4 in the HL-1
cell line [46]. Tbx3, Tbx5 and
Gata4 binding peaks can also be
observed upstream of Nppb, a
gene showing a similar
expression proﬁle and response
to Tbx3. c Tbx3 binding peaks
surrounding the Bmp2 gene. The
upstream element, shown to
bind both Tbx3 and P300 [47],
was cloned (underlined in
green) upstream of a minimal
promoter driving luciferase.
Putative T-binding sequence is
shown at the bottom of the
panel. d Luciferase induction in
H10 cells, relative to the
minimal promoter only (Co), by
the putative enhancer (TBE)
described in c. The activity of
this element can be modulated
by the presence of Tbx3 and
Tbx5
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123development (Fig. 1)[ 10, 11, 14, 49, 50]. However, Tbx2/3
double mutant embryos largely failed to establish a mor-
phological AVC. Noteworthy, the Cre inserts in the Tbx2
and Tbx3 loci are expressed in the putative AVC region of
double mutants, indicating that the upstream regulatory
pathway for AVC localized Tbx2/3 activation (most likely
involving Bmp2) has been active. Bmp2 in the AVC
myocardium induces Tbx2 through Smads in vivo [3, 7, 8],
and was also required for Tbx3 expression (Fig. 3a). Both
Tbx2 and Tbx3, in turn, were found to be required and
sufﬁcient to maintain expression of Bmp2. These ﬁndings
indicate that a feed-forward loop activates and maintains
Bmp2 and Tbx2/3 expression, respectively, in the AVC.
We anticipate the presence of at least one more layer of
regulation for AVC localized expression upstream of
Bmp2,a sBmp2 (lacking exon 3) expression itself in the
Bmp2 conditional KO is localized in the putative AVC
region (Fig. 3)[ 3, 7, 8]. The redundancy of the paralogous
T-box factor genes is limited to sites of co-expression. In
the AVC, Tbx2 is expressed in a slightly broader and left-
sided dominant manner, and indeed, Tbx2 mutants display
a left-sided AVC malformation that functions as an
accessory pathway causing ventricular pre-excitation [12].
Tbx3 expression is unique in the sinus node and AV bun-
dle, which are severely affected in Tbx3 mutants [1].
Moreover, expression of Tbx3 is maintained in the AVC,
unlike Tbx2 and Bmp2, and may be responsible for the
maintenance of the pacemaker-like tissue of the AV con-
duction system. The double dose of the redundant T-box
factors in the AVC may serve to ﬁrmly establish the AVC
phenotype during early stages of cardiogenesis.
Gain-of-function scenarios revealed that both Tbx2 and
Tbx3 are able to suppress expression of speciﬁc chamber
marker genes and differentiation [13, 26, 51, 52]. Using
expression proﬁling, we now identiﬁed of a broad spectrum
of working myocardium associated genes, including sarco-
mere components and mitochondrial genes, suppressed by
Tbx3,andinductionofgenesassociatedwiththepacemaker/
conduction system in the atrial working myocardium. These
programsunderliethetypicalphenotypeofAVC/conduction
system myocardium [1], suggesting that Tbx3 to a large
degree is responsible for this pacemaker phenotype. The
ChIP-seq analysis identiﬁed binding sites of Tbx3 in genes
both up- and down-regulated by Tbx3 in myocardium,
implying that Tbx3 directly regulates these genes in vivo.
BothTbx2andTbx3have context-dependent repression and
activationdomains,andcaninteractwithmultipleco-factors
that may provide repression or activation activities to the
protein complex [53]. The regulatory DNA regions that
control expression of Bmp2 and other genes in the heart in
vivo have not been established [54]. Whether the T-box
factor-sensitive enhancer we identiﬁed regulates cardiac
Bmp2 expression in vivo remains to be established.
Tbx2 and Tbx3 induce AV cushion development
Embryos with less than two alleles of Tbx2/Tbx3 failed to
establish AV cushions, which are the precursors of the
valves, and contribute to the septal structures and to the
ﬁbrous insulation. Conversely, ectopic expression of either
Tbx2 or Tbx3 in the myocardium of the developing heart
caused the initiation of cushion formation. These obser-
vations revealed that Tbx2 and Tbx3 in the AVC are
redundantly required and sufﬁcient to initiate cushion for-
mation in the AVC. The mechanism of cushion formation
has been extensively studied, and important roles for
ligands and receptors of the Tgf-b-superfamily have been
exposed [2]. Bmp2 expression in the AVC myocardium is
both required and sufﬁcient to induce cushion formation [3,
6, 7]. It activates Notch1, Twist1 and Tgfb2 in the endo-
cardium, which subsequently regulate Snai1,2 and EMT [2,
4]. A previous report implicated Tbx2 in the direct acti-
vation of Tgfb2 and Has2 in myocardium, which
subsequently induce cardiac jelly formation and cushion
development. In that report, Tbx2 did not induce Bmp2 or
Bmp4 [9]. Our data do not conﬁrm this model, and indicate
a different mechanism. Inactivation of Tbx2/3 caused loss
of Bmp2 expression and vice versa, Tbx2 and Tbx3 in
myocardium directly activate Bmp2 (and Bmp4). Further,
inactivation of Tbx2/3 and of Bmp2 resulted in very similar
phenotypes, which included failed AV cushion develop-
ment and loss of expression of Tgfb2 and Has2. These data
indicate that Tbx2/3 and Bmp2 expression are interde-
pendent and part of the same regulatory network for AVC
development. Furthermore, Tgfb2, Has2 and other critical
components in the regulation of cushion development (e.g.,
Notch1, Snai1)[2–4] were activated indirectly and selec-
tively in the endocardium by myocardial Tbx2/3.
Consistently, our ChIP-seq data indicated that Tbx3 does
not interact with the putative TBEs in Has2 or Tgfb2 [9],
although the latter contain multiple other sites of Tbx3
interaction (Supplemental Fig. 7). Thus, endocardial acti-
vation by Tbx2/3 occurs via Bmp2 or another paracrine
signal. Together, our data indicate a mechanism in which
Tbx2/3 and Bmp2 maintain expression of each other in a
feed-forward loop, and provide evidence that Bmp2 indu-
ces expression of genes involved in cushion development
and EMT in the endocardium.
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